Evaxion Announces Closing of $15 Million Public Offering
February 06, 2024 08:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
SINTX Technologies Announces Closing of $4.0 Million Public Offering
February 02, 2024 14:33 ET
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, Feb. 02, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the...
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
February 01, 2024 16:22 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...
Evaxion Biotech Announces Pricing of $15 Million Public Offering
February 01, 2024 09:20 ET
|
Evaxion Biotech
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™...
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
January 31, 2024 11:15 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharmaceuticals (Nasdaq: SXTP) closes $2.4 million public offering.
SINTX Technologies Announces Pricing of $4.0 Million Public Offering
January 31, 2024 09:20 ET
|
SINTX Technologies, Inc.
SALT LAKE CITY, UT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, today announced the...
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
January 30, 2024 09:00 ET
|
Sixty Degrees Pharmaceuticals
60 Degrees Pharma announces a $2.4 mil public offering, with funds to be used for working capital, relaunching ARAKODA for malaria prevention, and research
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
January 25, 2024 20:58 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
January 23, 2024 17:45 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Genius Group Announces Closing of $8.25 Million Public Offering
January 17, 2024 11:30 ET
|
Genius Group Limited
SINGAPORE, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading entrepreneur edtech and education group, today announced the...